Hepcinat LP: Ledipasvir & Sofosbuvir Tablets for Hepatitis C Treatment

DISEASE/SYMPTOMS Sep 26, 2025
Natco Pharma has introduced Hepcinat LP, the first generic version of Sofosbuvir and Ledipasvir. This fixed-dose combination drug contains 400 mg of Sofosbuvir and 90 mg of Ledipasvir in a single tablet, making it a highly effective treatment for hepatitis C virus (HCV) infections.

Hepcinat LP product photo clearly showing the product package and tablets

Uses & Effectiveness
Hepcinat LP is a prescription medication specifically designed to treat chronic hepatitis C virus (HCV) infection. Studies show that Sofosbuvir-based regimens provide a higher cure rate with fewer side effects compared to older treatments that required pegylated interferon.

This combination therapy is effective against HCV genotypes 1, 2, 3, and 4, with or without ribavirin. Additionally, it can be prescribed for patients undergoing liver transplantation to prevent reinfection.

Dosage & Administration
Recommended Dosage: One tablet per day, swallowed whole with a glass of water.
Duration of Treatment: 12 to 24 weeks, depending on the extent of liver damage and response to therapy.
Medical Supervision: It is essential to take this medication under the guidance of a healthcare provider.

Doctor explaining Hepcinat LP dosage instructions to a patient in a clinical setting

Possible Side Effects
While Hepcinat LP is generally well-tolerated, some patients may experience mild to moderate side effects, including:

Headache
Loss of appetite
Sleep disturbances
Skin irritation or itching
In rare cases, more severe reactions may occur, such as:

Irregular heartbeat
Breathing difficulties
Swelling (hives, face, or throat)
Signs of infection
If you experience persistent or severe side effects, contact your healthcare provider immediately.

Precautions & Important Considerations
Inform your doctor if you are allergic to Ledipasvir, Sofosbuvir, or any other ingredients in the medication.
Disclose all medications, supplements, or herbal products you are taking before starting treatment.
Antacids containing aluminum hydroxide or magnesium hydroxide should be taken at least four hours after Hepcinat LP to prevent interaction.
Patients with kidney disease or severe liver impairment should consult a doctor before use.
Pregnant or nursing mothers should seek medical advice before taking this medication.

Medical diagram showing how Hepcinat LP (Ledipasvir & Sofosbuvir) inhibits hepatitis C virus replication in the liver

Storage & Other Important Information
Keep Hepcinat LP in its original container, tightly sealed.
Store at room temperature, away from moisture and direct sunlight.
Do not use if the seal is broken or the medication is expired.
Keep out of reach of children.
Do not share this medication with others, even if they have similar symptoms.
Always follow your doctor’s instructions and appointments to ensure effective treatment and recovery from hepatitis C.
Hepcinat LP: Ledipasvir & Sofosbuvir Tablets for Hepatitis C Treatment - ZARVY Blog